Alexa Fluor® 647 Anti-Cytokeratin 14 antibody [EP1612Y]
- RabMAb
- Recombinant
- KO Validated
- 각 태그의 뜻
Be the first to review this product! 리뷰 제출
|
(3 제품이 사용된 논문 )
Rabbit Recombinant Monoclonal Cytokeratin 14 antibody - conjugated to Alexa Fluor® 647. Suitable for IHC-P, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 3 publications.
대체 명칭 보기
Cytokeratin-14, Keratin-14, CK-14, K14, KRT14
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Alexa Fluor® 647 Anti-Cytokeratin 14 antibody [EP1612Y] (AB192056)
ab192056 staining KRT14 in wild-type A431 cells (top panel) and KRT14 knockout A431 cells (bottom panel). The cells were fixed with 100% methanol (5 min) then permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab192056 at 1/100 dilution and ab195887 (Mouse monoclonal to alpha Tubulin - Alexa Fluor® 488) at 1/250 dilution overnight at 4°C. Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems TCS SP8).
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Alexa Fluor® 647 Anti-Cytokeratin 14 antibody [EP1612Y] (AB192056)
ab192056 staining Cytokeratin 14 in A431 cells. The cells were fixed with 100% methanol (5min), permeabilized in 0.1% Triton X-100 for 5 minutes and then blocked in 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab192056 at a working dilution of 1 in 100 (shown in red) and ab7291 (Mouse monoclonal [DM1A] to alpha Tubulin) at 1μg/ml overnight at +4°C, followed by a further incubation at room temperature for 1h with an Alexa Fluor® 488 Goat anti-Mouse secondary (ab150117) at 2μg/ml (shown in green). Nuclear DNA was labelled in blue with DAPI.
This product gave a positive signal in 4% formaldehyde (10min) fixed HeLa cells under the same testing conditions.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Alexa Fluor® 647 Anti-Cytokeratin 14 antibody [EP1612Y] (AB192056)
Immunohistochemical analysis of paraffin-embedded Human skin tissue labelling Anti-Cytokeratin 14 with ab192056 at 1/50 (10.0 ug/ml) dilution.
Positive staining on Human skin.
The primary antibody was incubated for 60 mins at room temperature (shown in magenta). Nuclear DNA was labelled with DAPI (shown in blue). The section was then mounted using Fluoromount®.
The immunostaining was performed on a Leica Biosystems BOND RX instrument. Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 40 mins.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Alexa Fluor® 647 Anti-Cytokeratin 14 antibody [EP1612Y] (AB192056)
Immunohistochemical analysis of paraffin-embedded Human skeletal muscle tissue labelling Anti-Cytokeratin 14 with ab192056 at 1/50 (10.0 ug/ml) dilution.
Negative control : no staining on Human skeletal muscle.
The primary antibody was incubated for 60 mins at room temperature (shown in magenta). Nuclear DNA was labelled with DAPI (shown in blue). The section was then mounted using Fluoromount®.
The immunostaining was performed on a Leica Biosystems BOND RX instrument. Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 40 mins.
- IHC
CiteAb
Immunohistochemistry - Alexa Fluor® 647 Anti-Cytokeratin 14 antibody [EP1612Y] (AB192056)
Immunohistochemistry-immunofluorescence using Alexa Fluor® 647 Anti-Cytokeratin 14 antibody [EP1612Y], ab192056. Publication image from Sun, S. et al., 2022, Nat Commun, 36123328. Legend direct from paper.
HSV infectivity at different stages of keratinocyte differentiation.a Schematic of HSV epidermal infection during keratinocytes differentiation in the skin-on-chip. Keratinocytes were infected with HSV (106 PFU) 1 day prior to air lifting or 1, 3, 5, 7, or 9 days post air lifting and examined 24 h post infection. b Representative cross-section H&E images of the skin-on-chip (mock infected) at different time points before and after air lifting. Scale bar : 20 µm. c Expression of keratinocyte differentiation marker Keratin 10 (K10) in mock infected skin-on-chip at times (indicated in b). K10 (green), DAPI (blue). Scale bars : 20 µm. d Expression of keratinocyte markers K10 and K14, basement membrane marker collagen IV (Col IV) and stromal marker vimentin (VIM) in the epidermis of skin-on-chip (left) compared with native human skin (right). Scale bars : 20 µm. e HSV infection in the epidermis of skin-on-chip by HSV-1 strain K26 (green, upper row) or by HSV-2 strain 186 (red, bottom row). DAPI (blue). Scale bar : 20 µm. f, g Infection was initiated at indicated keratincyte differentiation day and assessed 24 h later. Statistics generated by repeated measures one-way ANOVA with Tukey’s post-test and indicates difference from −1 day. f Quantification of virally infected cells and mean fluorescence intensity (MFI, *p = 0.0198, **p = 0.0012, ***p = 0.0003, **p = 0.0012, **p = 0.004) of viral gene expression for HSV-1 (n = 5). g Quantification of virally infected cells (***p = 0.0006) and MFI of viral gene expression for HSV-2 (n = 3). ****p < 0.0001 for all graphs. Data are provided in a Source data file.
- IHC
CiteAb
Immunohistochemistry - Alexa Fluor® 647 Anti-Cytokeratin 14 antibody [EP1612Y] (AB192056)
Immunohistochemistry-immunofluorescence using Alexa Fluor® 647 Anti-Cytokeratin 14 antibody [EP1612Y], ab192056. Publication image from Sun, S. et al., 2022, Nat Commun, 36123328. Legend direct from paper.
Skin-on-chip contains a stratified epidermis and dermis with a functional microvascular network.a, b Schematics of the major components in native human skin and skin-on-chip. c Representative 3-D reconstructed confocal image showing an overview of the cytoskeleton of the micro-engineered epidermis and dermis with underlying endothelialized microvascular network (white arrow indicates microfluidic flow direction). F-actin for cell cytoskeleton (green), DAPI for cell nucleus (blue). d Representative 3-D reconstructed confocal image illustrating basale (bottom, K14+) and corneous (upper, anucleate) layers in the epidermis of skin-on-chip. F-actin (green), K14 (red), DAPI (blue). Scale bar : 20 µm. e A cross-sectional view of hematoxylin–eosin (H&E) stained epidermis in the skin-on-chip. Scale bar : 20 µm. f Maximum intensity projected confocal image of an endothelialized microvascular network in the dermis after two weeks of culturing. F-actin (green), DAPI (blue). Scale bar : 100 µm. g Projected confocal images showing endothelium marker (CD31) expression, lumen formation (yz), and fibroblast capping of endothelial vessel (bottom). CD31 (green), Vimentin (red), DAPI (blue). Scale bar : 100 µm. h Representative fluorescence image after perfusion with 40 kDa FITC-Dextran through the microvasculature for 20 min. Graph depicts fluorescence intensity across the microvasculature inside the dashed box at 7 min (red) and 10 min after perfusion (blue). Scale bar : 100 µm. i F-actin cytoskeleton arrangement in endothelial cells and related flow shear force. Right : enlarged view within the white boxes. Scale bar : 100 µm. j Representative confocal image showing new sprouting from the main vessel lumen after angiogenetic stimuli. Right image shows cross-sectional view (yz). CD31 (green), Vimentin (red), DAPI (blue). Scale bar : 100 µm. Data are provided in a Source data file.
- IHC
CiteAb
Immunohistochemistry - Alexa Fluor® 647 Anti-Cytokeratin 14 antibody [EP1612Y] (AB192056)
Immunohistochemistry-immunofluorescence using Alexa Fluor® 647 Anti-Cytokeratin 14 antibody [EP1612Y], ab192056. Publication image from Sun, S. et al., 2022, Nat Commun, 36123328. Legend direct from paper.
HSV Infection in epidermis of human skin-on-chip and native human skin.a Schematic of epidermal HSV infection protocol by a biopsy punch. HSV-1 K26 virus (106 PFU) was added on top of the epithelium after the stratified epidermis was disrupted by a 1.5 mm biopsy punch. b GFP expression of HSV-1 K26-infected 3-D skin-on-chip epidermis at 24 h post infection. Image shown as a maximum intensity projection of confocal z stacks. HSV-1 K26 (green). Scale bar : 500 µm. c HSV infection in the epidermis of skin-on-chip. Arrows indicate margination of chromatin, enlargement of the cell nucleus, and multi-nucleation. F-actin (red), HSV-1 K26 (red), DAPI (blue). Scale bar : 20 µm. d Human ulcerative HSV lesion in a representative genital skin biopsy. HSV (green), DAPI (blue). Scale bar : 200 µm (upper) and 20 µm (lower). e HSV infection of the basal layer (indicated by K14 staining) of the 3-D skin-on-chip epidermis. HSV-1 K26 (green), DAPI (blue), K14 or K10 (red). Scale bar : 20 µm.
- IHC
CiteAb
Immunohistochemistry - Alexa Fluor® 647 Anti-Cytokeratin 14 antibody [EP1612Y] (AB192056)
Immunohistochemistry-immunofluorescence using Alexa Fluor® 647 Anti-Cytokeratin 14 antibody [EP1612Y], ab192056. Publication image from Sun, S. et al., 2022, Nat Commun, 36123328. Legend direct from paper.
Neutrophil migration and cytokine expression in human genital HSV ulcers.a Neutrophil infiltration from dermis into HSV-infected epidermis in a human skin biopsy representative of an ulcerative herpes lesion. CD15+ neutrophils (green), HSV (red). Scale bar : 100 µm. b Transcriptional levels of IL8, IL6, RANTES, and TNFA in human skin biopsies obtained from sites of HSV ulcerative lesion (n = 4) or from uninvolved contralateral controls (CTL, n = 3). Microarray data re-analyzed from a published data source45. *p = 0.0185 ***p < 0.0001 generated with paired two-tailed t-test. c Detection of epidermal IL8 RNA transcripts using fluorescence in situ hybridization (FISH) in human skin biopsies. HSV lesion (upper) and matched normal control at contralateral site (bottom). Enlarged image of dashed box in HSV lesion showing IL8 expression in K14+ basal keratinocytes (red, indicated by yellow arrows) and in K10+ differentiated keratinocytes (green, indicated by white arrows) (right). Scale bar : 100 µm. dRANTES RNA transcripts expression by FISH in control (left) and lesion (center and right) biopsies. Enlarged image of dashed box showing combined RANTES expression in K14+ keratinocytes and CD3+ T cells (top) and of only RANTES expression (bottom). K14 (red), CD3 (green), RANTES (white), DAPI (blue). Scale bar : 100 µm. eTNFA RNA transcripts expression by FISH in control (left) and lesion (right) biopsies. Enlarged image of dashed box (right). CD3 (green), TNFA (red), DAPI (blue). Scale bar : 100 µm. Data are provided in a Source data file.
- IHC
CiteAb
Immunohistochemistry - Alexa Fluor® 647 Anti-Cytokeratin 14 antibody [EP1612Y] (AB192056)
Immunohistochemistry-immunofluorescence using Alexa Fluor® 647 Anti-Cytokeratin 14 antibody [EP1612Y], ab192056. Publication image from Sun, S. et al., 2022, Nat Commun, 36123328. Legend direct from paper.
Neutrophil migration and cytokine expression in human genital HSV ulcers.a Neutrophil infiltration from dermis into HSV-infected epidermis in a human skin biopsy representative of an ulcerative herpes lesion. CD15+ neutrophils (green), HSV (red). Scale bar : 100 µm. b Transcriptional levels of IL8, IL6, RANTES, and TNFA in human skin biopsies obtained from sites of HSV ulcerative lesion (n = 4) or from uninvolved contralateral controls (CTL, n = 3). Microarray data re-analyzed from a published data source45. *p = 0.0185 ***p < 0.0001 generated with paired two-tailed t-test. c Detection of epidermal IL8 RNA transcripts using fluorescence in situ hybridization (FISH) in human skin biopsies. HSV lesion (upper) and matched normal control at contralateral site (bottom). Enlarged image of dashed box in HSV lesion showing IL8 expression in K14+ basal keratinocytes (red, indicated by yellow arrows) and in K10+ differentiated keratinocytes (green, indicated by white arrows) (right). Scale bar : 100 µm. dRANTES RNA transcripts expression by FISH in control (left) and lesion (center and right) biopsies. Enlarged image of dashed box showing combined RANTES expression in K14+ keratinocytes and CD3+ T cells (top) and of only RANTES expression (bottom). K14 (red), CD3 (green), RANTES (white), DAPI (blue). Scale bar : 100 µm. eTNFA RNA transcripts expression by FISH in control (left) and lesion (right) biopsies. Enlarged image of dashed box (right). CD3 (green), TNFA (red), DAPI (blue). Scale bar : 100 µm. Data are provided in a Source data file.
관련 conjugated 항체와 다양한 조성의 항체 (5)
-
Anti-Cytokeratin 14 antibody [EP1612Y]
-
Anti-Cytokeratin 14 antibody [EP1612Y] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Cytokeratin 14 antibody [EP1612Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Cytokeratin 14 antibody [EP1612Y]
-
578 PE
PE Anti-Cytokeratin 14 antibody [EP1612Y]
Reactivity 정보
제품 세부 정보
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Alexa Fluor® is a registered trademark of Molecular Probes, Inc, a Thermo Fisher Scientific Company. The Alexa Fluor® dye included in this product is provided under an intellectual property license from Life Technologies Corporation. As this product contains the Alexa Fluor® dye, the purchase of this product conveys to the buyer the non-transferable right to use the purchased product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). As this product contains the Alexa Fluor® dye the sale of this product is expressly conditioned on the buyer not using the product or its components, or any materials made using the product or its components, in any activity to generate revenue, which may include, but is not limited to use of the product or its components: in manufacturing; (ii) to provide a service, information, or data in return for payment (iii) for therapeutic, diagnostic or prophylactic purposes; or (iv) for resale, regardless of whether they are sold for use in research. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, 5781 Van Allen Way, Carlsbad, CA 92008 USA or outlicensing@thermofisher.com.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein significantly contributes to the maintenance and regeneration of epithelial tissues by forming a network of filaments with keratin 5. KRT14 pairs with keratin 5 to create a keratin intermediate filament complex which plays a structural role in the resilience and elasticity of epithelial tissues. This partnership is essential for the assembly of the cytoskeleton and supports the protective barrier function of the skin and related tissues.
Pathways
Cytokeratin 14 engages in pivotal cellular processes like keratinization and wound healing. The protein is actively involved in signal transduction pathways such as the epithelial cell differentiation pathway. Within these pathways KRT14 collaborates with KRT5 and other structural proteins to regulate cell proliferation and differentiation reflecting its importance in skin health and function.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
제품이 사용된 논문 (3)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Nature communications 13:5481 PubMed36123328
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature cancer 3:1071-1087 PubMed36065066
2022
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 6:35544 PubMed27762336
2016
Applications
ICC/IF
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com